Diseases with Cyclic Fevers
The primary diseases associated with cyclic/periodic fevers are the hereditary recurrent fever (HRF) syndromes, which include Familial Mediterranean Fever (FMF), Mevalonate Kinase Deficiency (MKD), Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS), and Cryopyrin-Associated Periodic Syndromes (CAPS). 1
Monogenic Autoinflammatory Diseases
These are the best-characterized conditions presenting with cyclic fevers:
Recessive Inheritance Pattern:
- Familial Mediterranean Fever (FMF) - Most common periodic fever syndrome, particularly prevalent in Mediterranean and Middle Eastern populations 1, 2
- Mevalonate Kinase Deficiency (MKD) - Fever episodes lasting 4-6 days with gastrointestinal symptoms, rash, cervical lymphadenopathy, and aphthous stomatitis 3
Dominant Inheritance Pattern:
- TRAPS (Tumor Necrosis Factor Receptor-Associated Periodic Syndrome) - Characterized by migratory rash, periorbital edema, and myalgia; has the longest diagnostic delay 3, 2
- CAPS (Cryopyrin-Associated Periodic Syndromes) - Presents with urticaria-like rash, progressive hearing loss, and potential neurologic involvement in severe forms 3
Additional Periodic Fever Conditions
PFAPA Syndrome
Periodic Fever, Aphthous stomatitis, Pharyngitis, and Adenitis - the most common self-limited periodic fever disorder in children without clear genetic disposition 4, 5. This presents with clockwork periodicity and is benign.
Cyclic Neutropenia
Should be considered when fever cycles occur approximately every 21 days 5. One case of SRP54 deficiency causing congenital neutropenia with cyclic pattern has been documented 6.
Key Clinical Distinguishing Features
Attack Duration and Pattern:
- MKD: 4-6 day episodes 3
- PFAPA: Stereotypical febrile illnesses with clockwork periodicity 5
- Cyclic neutropenia: ~21-day cycles 5
Associated Symptoms by Disease:
- CAPS: Urticaria-like rash, conjunctivitis, hearing loss, headaches 3
- TRAPS: Migratory rash, periorbital edema, abdominal/chest/testicular pain 3
- MKD: Urticarial or maculopapular rash, severe abdominal pain with vomiting/diarrhea, cervical lymphadenopathy 3
- FMF: Serosal inflammation (peritonitis, pleuritis) 1
Critical Pitfalls
Amyloidosis Risk: Uncontrolled disease in FMF, MKD, TRAPS, and CAPS can lead to AA amyloidosis, causing significant morbidity and mortality 3, 4. Monitor with urinalysis for proteinuria every 6-12 months 3.
Diagnostic Delay: TRAPS has the longest delay in diagnosis 2. When overlapping or atypical symptoms occur, screening multiple HRF genes may be necessary 1.
COVID-19 as Trigger: Recent evidence shows COVID-19 identified as a triggering factor in 54.5% of recurrent fever cases 6.
Monitoring Requirements
All patients require monitoring at each visit for 3:
- Systemic inflammation markers (ESR, CRP, CBC with differential, SAA)
- Disease-specific symptoms
- Growth, bone mineral density, sexual development
- Hepatosplenomegaly and lymphadenopathy